Kiew Ching Lee

Title: Kiew Ching Lee: Innovator in Pharmaceutical Compounds

Introduction

Kiew Ching Lee is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical compounds, particularly with his innovative work on compounds featuring a benzo seven-membered ring structure. His research has implications for drug development aimed at treating diseases related to BET Bromodomain BRD4 activity.

Latest Patents

Kiew Ching Lee holds a patent for a compound having a benzo seven-membered ring structure, along with its preparation method and uses. The patent describes a compound represented by a specific formula, which can be utilized in the preparation of drugs targeting diseases associated with BET Bromodomain BRD4 activity or expression levels. This invention includes various forms of the compound, such as enantiomers, diastereomers, racemates, and their mixtures, as well as chemically acceptable salts and crystalline hydrates.

Career Highlights

Kiew Ching Lee is currently associated with Bionna (Beijing) Medical Technology Co., Ltd. His work at this company focuses on advancing medical technology and drug development. His innovative approach and dedication to research have positioned him as a key figure in his field.

Collaborations

Kiew Ching Lee collaborates with talented professionals, including Hao Li and Jin Long Bai. These collaborations enhance the research and development efforts within his company, fostering an environment of innovation and discovery.

Conclusion

Kiew Ching Lee's contributions to the field of pharmaceutical compounds demonstrate his commitment to advancing medical science. His patent on the benzo seven-membered ring structure compound highlights his innovative spirit and potential impact on drug development.